Safety of intra-amniotic digoxin administration before late second- trimester abortion by dilation and evacuation

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 5, 2000, Pages 1063-1066

  Drey, Eleanor A ^a   Thomas, Lisa J ^a   Benowitz, Neal L ^b   Goldschlager, Nora ^b   Darney, Philip D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Digoxin; Dilation and evacuation; Second trimester abortion; Therapeutic abortion

Indexed keywords

DIGOXIN; FIBRINOGEN; PROTHROMBIN; THROMBOPLASTIN;

ADULT; AMNIOCENTESIS; AMNION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CURETTAGE; DIGOXIN BLOOD LEVEL; DRUG ABSORPTION; DRUG SAFETY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART RHYTHM; HOLTER MONITORING; HUMAN; PARTIAL THROMBOPLASTIN TIME; PHASE 1 CLINICAL TRIAL; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROTHROMBIN TIME; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY;

EID: 0034120619     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.105438     Document Type: Article

References (5)

1. 1. Abortion surveillance: preliminary data - United States, 1995. MMWR Morb Mortal Wkly Rep 1998;47(SS-2):31-40.
2. 2. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972-1987. Am J Obstet Gynecol 1994;171:1365-72.
3. 3. Hern WM, Zen C, Ferguson KA, Hart V, Haseman MV. Outpatient abortion for fetal anomaly and fetal death from 15-34 menstrual weeks' gestation: techniques and clinical management. Obstet Gynecol 1993;81:301-6.
4. 4. Massie B, Scheinman MM, Peters R, Desai J, Hirschfeld D, O'Young J. Clinical and electrophysiologic findings in patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II atrioventricular block. Circulation 1978;58:305-14.
5. 5. Lee TH, Smith TW. Serum digoxin concentration and diagnosis of digitalis toxicity: current concepts. Clin Pharmacokinet 1983;8:279-85.